Evidence map›Paper›PMID 38647623›Full record

ArticleBioresources and bioprocessing2023

Sustainable production of bacterioruberin carotenoid and its derivatives from Arthrobacter agilis NP20 on whey-based medium: optimization and product characterization.

Nehad Noby, Sherine N Khattab, Nadia A Soliman

Open access · diamondAbstract read
In one paragraph

Article in Bioresources and bioprocessing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. A New Era for Using Natural Pigments: The Case of the CBiotechnology and applied biochemistry · 2026
    Review
  2. Microbial conversion of biodiesel waste for carotenoid production.Frontiers in bioengineering and biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Microbial Bacterioruberin: A Comprehensive Review.Indian journal of microbiology · 2024
    Review
  10. Skin Protection by Carotenoid Pigments.International journal of molecular sciences · 2024
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nehad NobyDepartment of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, 21526, Egypt. igsr.nehad-noby@alexu.edu.eg.ORCID http://orcid.org/0000-0002-3420-6168
Sherine N KhattabDepartment of Chemistry, Faculty of Science, Alexandria University, Alexandria, 21321, Egypt.
Nadia A SolimanBioprocess Development Department, Genetic Engineering & Biotechnology Research Institute (GEBRI), City of Scientific Research & Technological Applications, (SRTA-City), New Borg Elarab, Alexandria, Egypt.
Alexandria University · EGCity of Scientific Research and Technological Applications · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterioruberin and its rare glycosylated derivatives are produced by Arthrobacter agilis as an adaptation strategy to low temperature conditions. The high antioxidant properties of bacterioruberin held great promise for different future applications like the pharmaceutical and food industries. Microbial production of bacterioruberin via a cost-effective medium will help increase its commercial availability and industrial use. The presented study aims to optimize the production of the rare C

Indexed as

Arthrobacter agilisCost-effective mediumGlycosylated bacterioruberin derivativesRadical scavenging activityResponse surface methodologyValorization of cheese whey

Identifiers

PMID38647623
PMCPMC10991996
OpenAlexW4385191518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.